BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 15010880)

  • 21. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
    Park SS; Kim SW
    Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.
    Kusińska R; Potemski P; Jesionek-Kupnicka D; Kordek R
    Pol J Pathol; 2005; 56(3):107-10. PubMed ID: 16334976
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Solid neuroendocrine breast carcinomas: incidence, clinico-pathological features and immunohistochemical profiling.
    López-Bonet E; Alonso-Ruano M; Barraza G; Vazquez-Martin A; Bernadó L; Menendez JA
    Oncol Rep; 2008 Dec; 20(6):1369-74. PubMed ID: 19020716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Primary cutaneous neuroendocrine cell carcinoma (Merkel cell carcinoma) with prominent microcystic features, mimicking eccrine carcinoma.
    Li N; Wolgamot G; Argenyi Z
    J Cutan Pathol; 2007 May; 34(5):410-4. PubMed ID: 17448197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
    Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
    Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunophenotypic comparison of salivary gland oncocytoma and metastatic renal cell carcinoma.
    Ozolek JA; Bastacky SI; Myers EN; Hunt JL
    Laryngoscope; 2005 Jun; 115(6):1097-100. PubMed ID: 15933529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncocytic carcinoma of the breast: frequency, morphology and follow-up.
    Ragazzi M; de Biase D; Betts CM; Farnedi A; Ramadan SS; Tallini G; Reis-Filho JS; Eusebi V
    Hum Pathol; 2011 Feb; 42(2):166-75. PubMed ID: 21111455
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential immunohistochemical and biological profile of squamous cell carcinoma of the breast.
    Grenier J; Soria JC; Mathieu MC; Andre F; Abdelmoula S; Velasco V; Morat L; Besse B; Dunant A; Spielmann M; Delaloge S
    Anticancer Res; 2007; 27(1B):547-55. PubMed ID: 17348440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Glycogen-rich clear-cell breast carcinoma with neuroendocrine differentiation features].
    Di Tommaso L; Pasquinelli G; Portincasa G; Santini D
    Pathologica; 2001 Dec; 93(6):676-80. PubMed ID: 11785121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroendocrine carcinoma of the breast--diagnostic and clinical implications.
    Watrowski R; Jäger C; Mattern D; Horst C
    Anticancer Res; 2012 Nov; 32(11):5079-82. PubMed ID: 23155283
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuroendocrine breast carcinoma metastatic to renal cell carcinoma and ipsilateral adrenal gland.
    Ulamec M; Tomas D; Perić-Balja M; Spajić B; Hes O; Kruslin B
    Pathol Res Pract; 2008; 204(11):851-5. PubMed ID: 18538946
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ovarian nonsmall cell neuroendocrine carcinoma: a clinicopathologic and immunohistochemical study of 11 cases.
    Veras E; Deavers MT; Silva EG; Malpica A
    Am J Surg Pathol; 2007 May; 31(5):774-82. PubMed ID: 17460463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Id4 messenger RNA and estrogen receptor expression: inverse correlation in human normal breast epithelium and carcinoma.
    de Candia P; Akram M; Benezra R; Brogi E
    Hum Pathol; 2006 Aug; 37(8):1032-41. PubMed ID: 16867866
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of her-2/neu gene amplification with other prognostic and predictive factors in female breast carcinoma.
    Ariga R; Zarif A; Korasick J; Reddy V; Siziopikou K; Gattuso P
    Breast J; 2005; 11(4):278-80. PubMed ID: 15982396
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prostate-specific antigen may serve as a pathological predictor in breast cancer.
    Nariţa D; Anghel A; Motoc M
    Rom J Morphol Embryol; 2008; 49(2):173-80. PubMed ID: 18516323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. E-cadherin status in breast cancer correlates with histologic type but does not correlate with established prognostic parameters.
    Qureshi HS; Linden MD; Divine G; Raju UB
    Am J Clin Pathol; 2006 Mar; 125(3):377-85. PubMed ID: 16613340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Triple-negative breast carcinoma in women from Vietnam and the United States: characterization of differential marker expression by tissue microarray.
    Williams DJ; Cohen C; To TV; Page AJ; Lawson D; Sussman ZM; Nassar A
    Hum Pathol; 2009 Aug; 40(8):1176-81. PubMed ID: 19368951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations of estrogen receptors, progesterone receptors and c-erbB2 oncogene protein expression in ductal carcinomas of the breast.
    Hussein MR; Abd-Elwahed SR; Abdulwahed AR
    Cell Biol Int; 2008 Jun; 32(6):698-707. PubMed ID: 18296077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Composite intestinal-type adenocarcinoma and small cell carcinoma of sinonasal tract.
    Jain R; Gramigna V; Sanchez-Marull R; Perez-Ordoñez B
    J Clin Pathol; 2009 Jul; 62(7):634-7. PubMed ID: 19321468
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Combined large cell neuroendocrine and endometrioid carcinoma of the endometrium.
    Mulvany NJ; Allen DG
    Int J Gynecol Pathol; 2008 Jan; 27(1):49-57. PubMed ID: 18156975
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.